Details of the Drug Formulaction

General Information of Drug Formulation (ID: F21092)

• Formulation Name: Ticlopidine 250 mg tablet
• Company: AvKARE; Teva Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Ticlopidine	(DMO946V)	Acute coronary syndrome	BA41	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Butylhydroxyanisole	(E00308)	24667	Antimicrobial preservative; Antioxidant
Magnesium stearate	(E00208)	11177	lubricant
Povidone	(E00667)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Stearic acid	(E00079)	5281	Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent